+0.34%
Today
Loading 1D prices…
Company profile
Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body's vasculature for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts
Sector
Health Care
Industry
Surgical & Medical Instruments & Apparatus
Exchange
Nasdaq
Display currency
USD
Location
Hingham, MA, United States
Employees
43
Fiscal year end
1231
CIK
883975
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| LNSRLENSAR Inc. Common Stock | $93.4M | $51.7M | -66.36% | -$2.87 | -5.59% | Buy |
| GUTSFractyl Health Inc. Common Stock | $101.9M | $0.00 | — | -$1.86 | -0.47% | Buy |
| SKINSkinHealth Systems Inc. Class A Common Stock | $91.1M | $300.8M | -3.16% | -$0.16 | +1.45% | Sell |
| PYPDPolyPid Ltd. Ordinary Shares | $104.6M | $0.00 | — | $2.09 | -0.19% | Buy |
| LUNGPulmonx Corporation Common Stock | $79.5M | $90.5M | -59.67% | -$1.33 | +0.54% | Buy |